IBT
OPTN

International Biotechnology Trust’s OptiNose OPTN Stock Holding History

International Biotechnology Trust’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-4,333
Closed -$1.3M – 59
2018
Q1 		$1.3M Hold
4,333
– – 0.51% 45
2017
Q4 		$1.23M Buy
+4,333
New +$1.22M 0.43% 48

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

International Biotechnology Trust's OPTN Position: Q2 2018 in Review

International Biotechnology Trust sold out of OptiNose (OPTN) in Q2 2018, closing a stake of 4,333 shares — an estimated $1.3M sold.

International Biotechnology Trust first reported a position in OPTN in Q4 2017 and held it in 2 quarters. The position peaked at $1.3M in Q1 2018. 72 funds tracked by Wall St. Rank hold OPTN as of Q2 2018.

  • International Biotechnology Trust reported no remaining OptiNose position as of Q2 2018 after selling out during the quarter.
  • International Biotechnology Trust sold 4,333 OptiNose shares in Q2 2018, an estimated $1.3M.
  • International Biotechnology Trust first reported a position in OptiNose in Q4 2017 and held it in 2 quarters.
  • International Biotechnology Trust's OptiNose position peaked at $1.3M in Q1 2018.
  • 72 funds tracked by Wall St. Rank held OptiNose as of Q2 2018.

Based on International Biotechnology Trust's 13F filing for Q2 2018, filed 13 Aug 2018.